CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tianda Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tianda Pharmaceuticals Ltd
Suites2405-2410, 24th Floor, CITIC Tower
No.1 Tim Mei Avenue
Phone: +852 25453313p:+852 25453313 Hong Kong Ticker: 455455
Business Summary
Tianda Pharmaceuticals Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The Company operates businesses in Hong Kong, China and Australia.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8069 Specialty hospitals, except psychiatric
8731 Commercial physical and biological research
6512 Operators of nonresidential buildings
6513 Operators of apartment buildings
2111 Cigarettes
1099 Miscellaneous metal ores, not elsewhere classified
8742 Management consulting services
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Wen QuanFang 53 1/25/2017 10/1/2003
Executive Director Man SangLui 58 9/30/2013 9/30/2013
Company Secretary Tai OnLo 3/31/2009 3/31/2009
5 additional Officers and Directors records available in full report.

Business Names
Business Name
455
Tianda Pharmaceuticals Limited
Yunnan Enterprises Holdings Limited

General Information
Number of Employees: 863 (As of 12/31/2023)
Outstanding Shares: 2,150,041,884 (As of 12/31/2023)
Shareholders: 1,793
Stock Exchange: HKG
Fax Number: +852 25416558


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024